- JP-listed companies
- Renascience Inc.
- Income statement
Renascience Inc.【JP:4889】Income statement
Market cap
¥19.4B
P/E ratio
-56.3x
| 2017/03 | 2018/03 | 2019/03 | 2020/03 | 2021/03 | 2022/03 | 2023/03 | 2024/03 | 2025/03 | |
| Revenue | 70 | 9 | - | 72 | 210 | 139 | 101 | 194 | 133 |
| Gross profit | - | - | - | 52 | 180 | 81 | 100 | 166 | 129 |
| Gross margin (%) | - | - | - | ||||||
| Operating income | - | - | - | -183 | -86 | -211 | -334 | -252 | -179 |
| Income before tax | -2 | -31 | -151 | -184 | -91 | -242 | -334 | -252 | -179 |
| Provision for income taxes | - | - | - | 0 | 0 | 1 | 2 | 2 | 30 |
| Net income | -2 | -70 | -151 | -184 | -100 | -254 | -336 | -258 | 113 |
| Earnings per share | -17,508.66 | -594,040.37 | -4,682.64 | -18.75 | -10.19 | -22.33 | -26.42 | -20.32 | 8.92 |
| Dividend per share | - | - | - | - | - | - | - | - | - |